Manufacturer Sourcing & Supply Chain Fulfillment

The contract entails the procurement of Methocarbamol Tablets from manufacturers registered with the FDA and possessing approved CAGE codes specified within the agreement, ensuring compliance with regulatory and supply chain requirements. The sourcing effort is managed under the Defense Logistics Agency within the Department of Defense, focusing exclusively on FDA-registered producers to guarantee product safety, quality, and authenticity throughout the supply chain. All manufacturers must be pre-vetted and listed in the contract’s approved vendor database to qualify for fulfillment. This subcontract, classified under NAICS code 325411 for pharmaceutical and biological product manufacturing, is part of a broader initiative to secure essential medications for military and defense-related medical needs. The contract was posted on July 15, 2026, and is tied to the procurement number SPE2DP26F7703 under the primary contract SPE2DX25D9900, with performance activities centered on the logistical and supply chain infrastructure managed by the Defense Logistics Agency. The terms require strict adherence to regulatory standards, timely delivery, and traceability of all manufactured lots to ensure uninterrupted availability of Methocarbamol Tablets for authorized recipients.